Kozak RW - Search Results

1

Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.

Tsudo M, Kozak RW, Goldman CK, Waldmann TA. Tsudo M, et al. Among authors: kozak rw. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9694-8. doi: 10.1073/pnas.83.24.9694. Proc Natl Acad Sci U S A. 1986. PMID: 3099289 Free PMC article.

2

Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.

Kozak RW, Atcher RW, Gansow OA, Friedman AM, Hines JJ, Waldmann TA. Kozak RW, et al. Proc Natl Acad Sci U S A. 1986 Jan;83(2):474-8. doi: 10.1073/pnas.83.2.474. Proc Natl Acad Sci U S A. 1986. PMID: 3079913 Free PMC article.

3

Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex.

Tsudo M, Kozak RW, Goldman CK, Waldmann TA. Tsudo M, et al. Among authors: kozak rw. Proc Natl Acad Sci U S A. 1987 Jun;84(12):4215-8. doi: 10.1073/pnas.84.12.4215. Proc Natl Acad Sci U S A. 1987. PMID: 3108887 Free PMC article.

4

Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-IL-2 receptor (Tac) monoclonal antibody.

Kozak RW, Fitzgerald DP, Atcher RW, Goldman CK, Nelson DL, Gansow OA, Pastan I, Waldmann TA. Kozak RW, et al. J Immunol. 1990 May 1;144(9):3417-23. J Immunol. 1990. PMID: 2139454

5

IL-2 receptors in adult T-cell leukemia: a target for immunotherapy.

Waldmann TA, Kozak RW, Tsudo M, Oh-ishi T, Bongiovanni KF, Goldman CK. Waldmann TA, et al. Among authors: kozak rw. Haematol Blood Transfus. 1987;31:110-5. doi: 10.1007/978-3-642-72624-8_23. Haematol Blood Transfus. 1987. PMID: 3127278 Review. No abstract available.

6

Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.

Kozak RW, Raubitschek A, Mirzadeh S, Brechbiel MW, Junghans RP, Gansow OA, Waldmann TA. Kozak RW, et al. Cancer Res. 1989 May 15;49(10):2639-44. Cancer Res. 1989. PMID: 2785435

7

Type I and II insulin-like growth factor receptors on human phytohemagglutinin-activated T lymphocytes.

Kozak RW, Haskell JF, Greenstein LA, Rechler MM, Waldmann TA, Nissley SP. Kozak RW, et al. Cell Immunol. 1987 Oct 15;109(2):318-31. doi: 10.1016/0008-8749(87)90315-7. Cell Immunol. 1987. PMID: 2959373

8

Interleukin 2 (IL2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptor.

Lorberboum-Galski H, Kozak RW, Waldmann TA, Bailon P, FitzGerald DJ, Pastan I. Lorberboum-Galski H, et al. Among authors: kozak rw. J Biol Chem. 1988 Dec 15;263(35):18650-6. J Biol Chem. 1988. PMID: 3143716 Free article.

9

IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells.

Kozak RW, Lorberboum-Galski H, Jones L, Puri RK, Willingham MC, Malek T, Fitzgerald DJ, Waldmann TA, Pastan I. Kozak RW, et al. J Immunol. 1990 Oct 15;145(8):2766-71. J Immunol. 1990. PMID: 2212661

10

Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.

Hartmann F, Horak EM, Garmestani K, Wu C, Brechbiel MW, Kozak RW, Tso J, Kosteiny SA, Gansow OA, Nelson DL, et al. Hartmann F, et al. Among authors: kozak rw. Cancer Res. 1994 Aug 15;54(16):4362-70. Cancer Res. 1994. PMID: 8044783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters